Financhill
Back

Ascendis Pharma AS Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
41

ASND
Ascendis Pharma AS

Last Price:
147.00
Seasonality Move:
6.54%
Sell
28

ALNY
Alnylam Pharmaceuticals

Last Price:
272.71
Seasonality Move:
5.61%
Sell
41
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $146.59. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $274.46. The Score for ALNY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $146.59
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $274.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.42 Sell
Relative Strength Index (14 RSI): 66.82 Buy
Chaikin Money Flow: 1073571 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (121.38 - 142.52) Buy
Bollinger Bands (100): (125.48 - 139.4) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.95 Buy
Relative Strength Index (14 RSI): 59.65 Buy
Chaikin Money Flow: 719597 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (256.31 - 277.53) Buy
Bollinger Bands (100): (161.67 - 267.41) Buy

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 122.89 Buy
20-day SMA: 130.17 Buy
50-day SMA: 132.66 Buy
200-day SMA: 135.12 Buy
8-day EMA: 128.84 Buy
20-day EMA: 128.79 Buy
50-day EMA: 131.25 Buy
200-day EMA: 129.25 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 261.21 Buy
20-day SMA: 266.87 Buy
50-day SMA: 259.05 Buy
200-day SMA: 190.61 Buy
8-day EMA: 265.35 Buy
20-day EMA: 263.87 Buy
50-day EMA: 251.75 Buy
200-day EMA: 206.68 Buy

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.77 per share, an increase next quarter of $1.90 per share, an increase this year of $1.68 per share, and an increase next year of $4.41 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):